Comparison of Hyperphagia and Behavioral Issues in Prader-Willi Syndrome (PWS) Patients Receiving Diazoxide Choline Extended-Release (DCCR) with Matched Participants in PATH for PWS Study (PfPWS NHS) (Poster Board 7)

Monday, April 25, 2022

8:00 AM – 9:30 AM US MT

Location: Convention Center: Mile High Ballroom 1EF

CE: Enduring CME: 0.25

Publication Number: 3100.1

Theresa V. Strong, Foundation for Prader-Willi Research, Walnut, CA, United States; Jennifer L. Miller, University of Florida, Gainesville, FL, United States; Anish Bhatnagar, Soleno Therapeutics, Redwood City, CA, United States

Presenting Author(s)

Theresa V. Strong, PhD
Director of Research Programs
Foundation for Prader-Willi Research
Walnut, California, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Theresa V. Strong, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Jennifer L. Miller, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Anish Bhatnagar, MD, MD: ● Soleno Therapeutics (Currently Ongoing) (Products/Services: Employment with an ineligible company, Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).